{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:46Z","timestamp":1790716966243,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 27386"],"award-info":[{"award-number":["IG 27386"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Prin 2022 PNRR P2022MALRP"],"award-info":[{"award-number":["Prin 2022 PNRR P2022MALRP"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Prin 2022 202282CMEA"],"award-info":[{"award-number":["Prin 2022 202282CMEA"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Prin 2022 2022Y79PT4"],"award-info":[{"award-number":["Prin 2022 2022Y79PT4"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07196-6","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:53:41Z","timestamp":1760453621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors"],"prefix":"10.1186","volume":"23","author":[{"given":"Marianna","family":"Talia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Scordamaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzurra","family":"Zicarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestina Marianna","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Malaguarnera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Cesario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Miglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maggiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Lappano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"7196_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31:1154\u201362.","journal-title":"Nat Med"},{"key":"7196_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10:49.","journal-title":"Signal Transduct Target Ther"},{"key":"7196_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5:66.","journal-title":"Nat Rev Dis Primers"},{"key":"7196_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11033-025-10558-4","volume":"52","author":"SK Ray","year":"2025","unstructured":"Ray SK, Mukherjee S. Clinical aspect of male breast cancer: a burgeoning and unaddressed issue. Mol Biol Rep. 2025;52:452.","journal-title":"Mol Biol Rep"},{"key":"7196_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11912-023-01489-z","volume":"26","author":"PV Bhardwaj","year":"2024","unstructured":"Bhardwaj PV, Gupta S, Elyash A, Teplinsky E. Male breast cancer: A review on diagnosis, treatment, and survivorship. Curr Oncol Rep. 2024;26:34\u201345.","journal-title":"Curr Oncol Rep"},{"key":"7196_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-015-0143-8","volume":"34","author":"L Di Lauro","year":"2015","unstructured":"Di Lauro L, Pizzuti L, Barba M, Sergi D, Sperduti I, Mottolese M, et al. Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study. J Exp Clin Cancer Res. 2015;34:26.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-021-03190-7","volume":"480","author":"S Fox","year":"2022","unstructured":"Fox S, Speirs V, Shaaban AM. Male breast cancer: an update. Virchows Arch. 2022;480:85\u201393.","journal-title":"Virchows Arch"},{"key":"7196_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-018-4921-9","volume":"173","author":"A Gucalp","year":"2019","unstructured":"Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019;173:37\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"7196_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrc2795","volume":"10","author":"GP Risbridger","year":"2010","unstructured":"Risbridger GP, Davis ID, Birrell SN, Tilley WD. Breast and prostate cancer: more similar than different. Nat Rev Cancer. 2010;10:205\u201312.","journal-title":"Nat Rev Cancer"},{"key":"7196_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41391-024-00825-z","volume":"28","author":"B Fang","year":"2025","unstructured":"Fang B, Lu Y, Li X, Wei Y, Ye D, Wei G, et al. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer. Prostate Cancer Prostatic Dis. 2025;28:260\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"7196_CR11","doi-asserted-by":"publisher","first-page":"13579","DOI":"10.1038\/s41598-019-49964-7","volume":"9","author":"KT Carm","year":"2019","unstructured":"Carm KT, Hoff AM, Bakken AC, Axcrona U, Axcrona K, Lothe RA, et al. Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer. Sci Rep. 2019;9:13579.","journal-title":"Sci Rep"},{"key":"7196_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.eururo.2018.08.009","volume":"75","author":"M L\u00f8vf","year":"2019","unstructured":"L\u00f8vf M, Zhao S, Axcrona U, Johannessen B, Bakken AC, Carm KT, et al. Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity. Eur Urol. 2019;75:498\u2013505.","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"7196_CR13","first-page":"S86","volume":"82","author":"K Mizuno","year":"2022","unstructured":"Mizuno K, Beltran H. Future directions for precision oncology in prostate cancer. Prostate. 2022;82(Suppl 1):S86\u201396.","journal-title":"Prostate"},{"key":"7196_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13046-021-02022-5","volume":"40","author":"P Hern\u00e1ndez-Camarero","year":"2021","unstructured":"Hern\u00e1ndez-Camarero P, L\u00f3pez-Ruiz E, Marchal JA, Per\u00e1n M. Cancer: a mirrored room between tumor bulk and tumor microenvironment. J Exp Clin Cancer Res. 2021;40:217.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri G, Tuveson DA. Activated fibroblasts in cancer: perspectives and challenges. Cancer Cell. 2023;41:434\u201349.","journal-title":"Cancer Cell"},{"key":"7196_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","volume":"6","author":"R Ge","year":"2022","unstructured":"Ge R, Wang Z, Cheng L. Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. NPJ Precis Oncol. 2022;6:31.","journal-title":"NPJ Precis Oncol"},{"key":"7196_CR17","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, Wagner F, Williams SR, Rouault M, et al. High resolution mapping of the tumor microenvironment using integrated single-cell, Spatial and in situ analysis. Nat Commun. 2023;14:8353.","journal-title":"Nat Commun"},{"key":"7196_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14728222.2020.1751819","volume":"24","author":"R Lappano","year":"2020","unstructured":"Lappano R, Rigiracciolo DC, Belfiore A, Maggiolini M, De Francesco EM. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert Opin Ther Targets. 2020;24:559\u201372.","journal-title":"Expert Opin Ther Targets"},{"key":"7196_CR19","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-23-2260","volume":"83","author":"X Li","year":"2023","unstructured":"Li X, Mu P. The critical interplay of CAF plasticity and resistance in prostate cancer. Cancer Res. 2023;83:2990\u20132.","journal-title":"Cancer Res"},{"key":"7196_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22:159.","journal-title":"Mol Cancer"},{"key":"7196_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046-023-02934-4","volume":"42","author":"R Melchionna","year":"2023","unstructured":"Melchionna R, Trono P, Di Carlo A, Di Modugno F, Nistic\u00f2 P. Transcription factors in fibroblast plasticity and CAF heterogeneity. J Exp Clin Cancer Res. 2023;42:347.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our Understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"7196_CR23","doi-asserted-by":"publisher","first-page":"216234","DOI":"10.1016\/j.canlet.2023.216234","volume":"566","author":"G Dong","year":"2023","unstructured":"Dong G, Chen P, Xu Y, Liu T, Yin R. Cancer-associated fibroblasts: key criminals of tumor pre-metastatic niche. Cancer Lett. 2023;566:216234.","journal-title":"Cancer Lett"},{"key":"7196_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","volume":"22","author":"E Di Carlo","year":"2024","unstructured":"Di Carlo E, Sorrentino C. The multifaceted role of the stroma in the healthy prostate and prostate cancer. J Transl Med. 2024;22:825.","journal-title":"J Transl Med"},{"key":"7196_CR25","doi-asserted-by":"publisher","first-page":"189291","DOI":"10.1016\/j.bbcan.2025.189291","volume":"1880","author":"J Yang","year":"2025","unstructured":"Yang J, Xin B, Wang X, Wan Y. Cancer-associated fibroblasts in breast cancer in the single-cell era: opportunities and challenges. Biochim Biophys Acta Rev Cancer. 2025;1880:189291.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7196_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12967-025-06376-8","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Ren B, Liu B, Wang R, Li S, Zhao Y, et al. Single-cell RNA sequencing and Spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer. J Transl Med. 2025;23:344.","journal-title":"J Transl Med"},{"key":"7196_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","volume":"23","author":"Y Liu","year":"2025","unstructured":"Liu Y, Dong G, Yu J, Liang P. Integration of single-cell and Spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: Spatial distribution, differentiation trajectories, and therapeutic potential. J Transl Med. 2025;23:198.","journal-title":"J Transl Med"},{"key":"7196_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12967-022-03463-y","volume":"20","author":"D Scordamaglia","year":"2022","unstructured":"Scordamaglia D, Cirillo F, Talia M, Santolla MF, Rigiracciolo DC, Muglia L, et al. Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells. J Transl Med. 2022;20:263.","journal-title":"J Transl Med"},{"key":"7196_CR29","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390.","journal-title":"Bioinformatics"},{"key":"7196_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"7196_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"key":"7196_CR32","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288\u201397.","journal-title":"Nucleic Acids Res"},{"key":"7196_CR33","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomart. Nat Protoc. 2009;4:1184\u201391.","journal-title":"Nat Protoc"},{"key":"7196_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011\u201325.","journal-title":"Cell"},{"key":"7196_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell. 2018;34:996\u2013e10118.","journal-title":"Cancer Cell"},{"key":"7196_CR36","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","volume":"74","author":"Q Long","year":"2014","unstructured":"Long Q, Xu J, Osunkoya AO, Sannigrahi S, Johnson BA, Zhou W, et al. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res. 2014;74:3228\u201337.","journal-title":"Cancer Res"},{"key":"7196_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11\u201322.","journal-title":"Cancer Cell"},{"key":"7196_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He Q-Y. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12:477\u20139.","journal-title":"Mol Biosyst"},{"key":"7196_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"7196_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/aps.2015.92","volume":"36","author":"X-X Sun","year":"2015","unstructured":"Sun X-X, Yu Q. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin. 2015;36:1219\u201327.","journal-title":"Acta Pharmacol Sin"},{"key":"7196_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/cac2.12291","volume":"42","author":"D Hu","year":"2022","unstructured":"Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, et al. Cancer-associated fibroblasts in breast cancer: challenges and opportunities. Cancer Commun. 2022;42:401\u201334.","journal-title":"Cancer Commun"},{"key":"7196_CR42","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"7196_CR43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"7196_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"key":"7196_CR45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"7196_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"key":"7196_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13046-022-02524-w","volume":"41","author":"S Rizzolio","year":"2022","unstructured":"Rizzolio S, Giordano S, Corso S. The importance of being CAFs (in cancer resistance to targeted therapies). J Exp Clin Cancer Res. 2022;41:319.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12967-025-06071-8","volume":"23","author":"S Zhou","year":"2025","unstructured":"Zhou S, Zhao Z, Wang Z, Xu H, Li Y, Xu K, et al. Cancer-associated fibroblasts in carcinogenesis. J Transl Med. 2025;23:50.","journal-title":"J Transl Med"},{"key":"7196_CR49","doi-asserted-by":"publisher","unstructured":"Bonollo F, Thalmann GN, Kruithof-de Julio M, Karkampouna S. The role of cancer-associated fibroblasts in prostate cancer tumorigenesis. Cancers [Internet]. 2020;12. Available from: https:\/\/doi.org\/10.3390\/cancers12071887.","DOI":"10.3390\/cancers12071887"},{"key":"7196_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/1061186X.2024.2418344","volume":"33","author":"Q Dai","year":"2025","unstructured":"Dai Q, Peng Y, He P, Wu X. Interactions and communications in the prostate tumour microenvironment: evolving towards effective cancer therapy. J Drug Target. 2025;33:295\u2013315.","journal-title":"J Drug Target"},{"key":"7196_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-023-04807-y","volume":"22","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Xie Z, Zhao J, Zhang Y, Ruan Y, et al. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. J Transl Med. 2024;22:57.","journal-title":"J Transl Med"},{"key":"7196_CR52","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1038\/s41467-023-41318-2","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun H, Zhang L, Wang Z, Gu D, Zhu M, Cai Y, et al. Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nat Commun. 2023;14:5590.","journal-title":"Nat Commun"},{"key":"7196_CR53","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s13402-024-00964-4","volume":"47","author":"C Yang","year":"2024","unstructured":"Yang C, Wang Z, Qian L, Fu J, Sun H. Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer. Cell Oncol. 2024;47:1831\u201343.","journal-title":"Cell Oncol"},{"key":"7196_CR54","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.3390\/ijms241713053","volume":"24","author":"H Kim","year":"2023","unstructured":"Kim H, Wisniewska K, Regner MJ, Thennavan A, Spanheimer PM, Franco HL. Single-cell transcriptional and epigenetic profiles of male breast cancer nominate salient cancer-specific enhancers. Int J Mol Sci. 2023;24:13053.","journal-title":"Int J Mol Sci"},{"key":"7196_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14:587.","journal-title":"Cell Death Dis"},{"key":"7196_CR56","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12885-024-12783-9","volume":"24","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Lai C, Hu J, Mulati Y, Xu X, Luo J, et al. Integrative analysis regarding the correlation between collagen-related genes and prostate cancer. BMC Cancer. 2024;24:1038.","journal-title":"BMC Cancer"},{"key":"7196_CR57","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-06-2163","volume":"13","author":"J Banyard","year":"2007","unstructured":"Banyard J, Bao L, Hofer MD, Zurakowski D, Spivey KA, Feldman AS, et al. Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases. Clin Cancer Res. 2007;13:2634\u201342.","journal-title":"Clin Cancer Res"},{"key":"7196_CR58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.2017.15","volume":"116","author":"A Rochette","year":"2017","unstructured":"Rochette A, Boufaied N, Scarlata E, Hamel L, Brimo F, Whitaker HC, et al. Asporin is a stromally expressed marker associated with prostate cancer progression. Br J Cancer. 2017;116:775\u201384.","journal-title":"Br J Cancer"},{"key":"7196_CR59","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1158\/0008-5472.CAN-18-2931","volume":"79","author":"RM Hughes","year":"2019","unstructured":"Hughes RM, Simons BW, Khan H, Miller R, Kugler V, Torquato S, et al. Asporin restricts mesenchymal stromal cell differentiation, alters the tumor microenvironment, and drives metastatic progression. Cancer Res. 2019;79:3636\u201350.","journal-title":"Cancer Res"},{"key":"7196_CR60","doi-asserted-by":"publisher","first-page":"e21692","DOI":"10.1096\/fj.202002558RR","volume":"35","author":"F Graf","year":"2021","unstructured":"Graf F, Horn P, Ho AD, Boutros M, Maercker C. The extracellular matrix proteins type I collagen, type III collagen, fibronectin, and laminin 421 stimulate migration of cancer cells. FASEB J. 2021;35:e21692.","journal-title":"FASEB J"},{"key":"7196_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11010-018-3399-4","volume":"451","author":"B Martinucci","year":"2019","unstructured":"Martinucci B, Minatel B, de Cucielo C, Medeiros MS, Vechetti-Junior M, Felisbino IJ. Basement membrane extract attenuates the more malignant gene expression profile accentuated by fibronectin in prostate cancer cells. Mol Cell Biochem. 2019;451:131\u20138.","journal-title":"Mol Cell Biochem"},{"key":"7196_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","volume":"38","author":"NI Nissen","year":"2019","unstructured":"Nissen NI, Karsdal M, Willumsen N. Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology. J Exp Clin Cancer Res. 2019;38:115.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR63","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov. 2024;14:1375\u201388.","journal-title":"Cancer Discov"},{"key":"7196_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21:217\u201338.","journal-title":"Nat Rev Cancer"},{"key":"7196_CR65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12967-022-03768-y","volume":"20","author":"B Deng","year":"2022","unstructured":"Deng B, Zhao Z, Kong W, Han C, Shen X, Zhou C. Biological role of matrix stiffness in tumor growth and treatment. J Transl Med. 2022;20:540.","journal-title":"J Transl Med"},{"key":"7196_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12967-025-06306-8","volume":"23","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D, et al. Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches. J Transl Med. 2025;23:313.","journal-title":"J Transl Med"},{"key":"7196_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/path.6207","volume":"262","author":"J Thorlacius-Ussing","year":"2024","unstructured":"Thorlacius-Ussing J, Jensen C, Nissen NI, Cox TR, Kalluri R, Karsdal M, et al. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J Pathol. 2024;262:22\u201336.","journal-title":"J Pathol"},{"key":"7196_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2023.09.012","volume":"144","author":"Y Ding","year":"2024","unstructured":"Ding Y, Bu P, Assylbekova B, Ruder S, Miles B, Sayeeduddin M, et al. Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death. Hum Pathol. 2024;144:1\u20137.","journal-title":"Hum Pathol"},{"key":"7196_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17:309.","journal-title":"J Transl Med"},{"key":"7196_CR70","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.trecan.2023.06.002","volume":"9","author":"H Su","year":"2023","unstructured":"Su H, Karin M. Collagen architecture and signaling orchestrate cancer development. Trends Cancer. 2023;9:764\u201373.","journal-title":"Trends Cancer"},{"key":"7196_CR71","doi-asserted-by":"publisher","first-page":"102497","DOI":"10.1016\/j.tice.2024.102497","volume":"90","author":"R Sowbhagya","year":"2024","unstructured":"Sowbhagya R, Muktha H, Ramakrishnaiah TN, Surendra AS, Sushma SM, Tejaswini C, et al. Collagen as the extracellular matrix biomaterials in the arena of medical sciences. Tissue Cell. 2024;90:102497.","journal-title":"Tissue Cell"},{"key":"7196_CR72","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15:307.","journal-title":"Cell Death Dis"},{"key":"7196_CR73","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","volume":"35","author":"M Fang","year":"2014","unstructured":"Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumour Biol. 2014;35:2871\u201382.","journal-title":"Tumour Biol"},{"key":"7196_CR74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ebiom.2016.10.012","volume":"13","author":"BA Morris","year":"2016","unstructured":"Morris BA, Burkel B, Ponik SM, Fan J, Condeelis JS, Aguirre-Ghiso JA, et al. Collagen matrix density drives the metabolic shift in breast cancer cells. EBioMedicine. 2016;13:146\u201356.","journal-title":"EBioMedicine"},{"key":"7196_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E17-01-0041","volume":"29","author":"MR Zanotelli","year":"2018","unstructured":"Zanotelli MR, Goldblatt ZE, Miller JP, Bordeleau F, Li J, VanderBurgh JA, et al. Regulation of ATP utilization during metastatic cell migration by collagen architecture. Mol Biol Cell. 2018;29:1\u20139.","journal-title":"Mol Biol Cell"},{"key":"7196_CR76","doi-asserted-by":"publisher","first-page":"17094","DOI":"10.1038\/s41598-018-35381-9","volume":"8","author":"EJ Mah","year":"2018","unstructured":"Mah EJ, Lefebvre AEYT, McGahey GE, Yee AF, Digman MA. Collagen density modulates triple-negative breast cancer cell metabolism through adhesion-mediated contractility. Sci Rep. 2018;8:17094.","journal-title":"Sci Rep"},{"key":"7196_CR77","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s43856-023-00428-0","volume":"4","author":"A Aggarwal","year":"2024","unstructured":"Aggarwal A, Khalighi S, Babu D, Li H, Azarianpour-Esfahani S, Corredor G, et al. Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. Commun Med (Lond). 2024;4:2.","journal-title":"Commun Med (Lond)"},{"key":"7196_CR78","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/jpm12040534","volume":"12","author":"H-J Shin","year":"2022","unstructured":"Shin H-J, Gil M, Lee I-S. Association of elevated expression levels of COL4A1 in stromal cells with an immunosuppressive tumor microenvironment in low-grade glioma, pancreatic adenocarcinoma, skin cutaneous melanoma, and stomach adenocarcinoma. J Pers Med. 2022;12:534.","journal-title":"J Pers Med"},{"key":"7196_CR79","doi-asserted-by":"publisher","unstructured":"Qian X, Jia W, Li Y, Chen J, Zhang J, Sun Y. COL4A1 promotes gastric cancer progression by regulating tumor invasion, tumor microenvironment and drug sensitivity. Curr Med Chem [Internet]. 2025;32. Available from: https:\/\/doi.org\/10.2174\/0109298673351943250314074632.","DOI":"10.2174\/0109298673351943250314074632"},{"key":"7196_CR80","doi-asserted-by":"publisher","first-page":"147573","DOI":"10.1016\/j.gene.2023.147573","volume":"878","author":"F Wei","year":"2023","unstructured":"Wei F, Li T, Li J, Zhang Y, Liu T, Zhao Z, et al. Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer. Gene. 2023;878:147573.","journal-title":"Gene"},{"key":"7196_CR81","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/1078-0432.CCR-15-0256","volume":"22","author":"PJ Hurley","year":"2016","unstructured":"Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, et al. Germline variants in Asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer. Clin Cancer Res. 2016;22:448\u201358.","journal-title":"Clin Cancer Res"},{"key":"7196_CR82","doi-asserted-by":"publisher","first-page":"189029","DOI":"10.1016\/j.bbcan.2023.189029","volume":"1879","author":"SP Lall","year":"2024","unstructured":"Lall SP, Alsafwani ZW, Batra SK, Seshacharyulu P. ASPORIN: A root of the matter in tumors and their host environment. Biochim Biophys Acta Rev Cancer. 2024;1879:189029.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7196_CR83","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1373\/clinchem.2011.171637","volume":"58","author":"EW Klee","year":"2012","unstructured":"Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, et al. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem. 2012;58:599\u2013609.","journal-title":"Clin Chem"},{"key":"7196_CR84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12014-024-09490-9","volume":"21","author":"Y Huang","year":"2024","unstructured":"Huang Y, Yang G, Yao X, Fang Y, Lin Q, Zhou M, et al. Proteomic profiling of prostate cancer reveals molecular signatures under antiandrogen treatment. Clin Proteom. 2024;21:44.","journal-title":"Clin Proteom"},{"key":"7196_CR85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12094-022-02968-8","volume":"25","author":"B Guo","year":"2023","unstructured":"Guo B, Wang Y, Liu W, Zhang S. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types. Clin Transl Oncol. 2023;25:535\u201354.","journal-title":"Clin Transl Oncol"},{"key":"7196_CR86","doi-asserted-by":"publisher","first-page":"98298","DOI":"10.18632\/oncotarget.21176","volume":"8","author":"E Englund","year":"2017","unstructured":"Englund E, Canesin G, Papadakos KS, Vishnu N, Persson E, Reitsma B, et al. Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis. Oncotarget. 2017;8:98298\u2013311.","journal-title":"Oncotarget"},{"key":"7196_CR87","doi-asserted-by":"publisher","first-page":"1167659","DOI":"10.3389\/fimmu.2023.1167659","volume":"14","author":"AM Blom","year":"2023","unstructured":"Blom AM, Gialeli C, Hagerling C, Berntsson J, Jirstr\u00f6m K, Papadakos KS. Expression of cartilage oligomeric matrix protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression. Front Immunol. 2023;14:1167659.","journal-title":"Front Immunol"},{"key":"7196_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.matbio.2017.01.001","volume":"60\u201361","author":"LA Griggs","year":"2017","unstructured":"Griggs LA, Hassan NT, Malik RS, Griffin BP, Martinez BA, Elmore LW, et al. Fibronectin fibrils regulate TGF-\u03b21-induced Epithelial-Mesenchymal transition. Matrix Biol. 2017;60\u201361:157\u201375.","journal-title":"Matrix Biol"},{"key":"7196_CR89","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","volume":"40","author":"S Spada","year":"2021","unstructured":"Spada S, Tocci A, Di Modugno F, Nistic\u00f2 P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J Exp Clin Cancer Res. 2021;40:102.","journal-title":"J Exp Clin Cancer Res"},{"key":"7196_CR90","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12967-024-05413-2","volume":"22","author":"M Talia","year":"2024","unstructured":"Talia M, Cesario E, Cirillo F, Scordamaglia D, Di Dio M, Zicarelli A, et al. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. J Transl Med. 2024;22:597.","journal-title":"J Transl Med"},{"key":"7196_CR91","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10549-023-07032-9","volume":"201","author":"C Chen","year":"2023","unstructured":"Chen C, Ye L, Yi J, Liu T, Li Z. FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer. Breast Cancer Res Treat. 2023;201:515\u201333.","journal-title":"Breast Cancer Res Treat"},{"key":"7196_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-95693-0_1","volume":"1095","author":"H Schatten","year":"2018","unstructured":"Schatten H. Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies. Adv Exp Med Biol. 2018;1095:1\u201314.","journal-title":"Adv Exp Med Biol"},{"key":"7196_CR93","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/his.13767","volume":"74","author":"CF Kweldam","year":"2019","unstructured":"Kweldam CF, van Leenders GJ, van der Kwast T. Grading of prostate cancer: a work in progress. Histopathology. 2019;74:146\u201360.","journal-title":"Histopathology"},{"key":"7196_CR94","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/MOU.0000000000000419","volume":"27","author":"S Loeb","year":"2017","unstructured":"Loeb S, Ross AE. Genomic testing for localized prostate cancer: where do we go from here? Curr Opin Urol. 2017;27:495\u20139.","journal-title":"Curr Opin Urol"},{"key":"7196_CR95","doi-asserted-by":"crossref","unstructured":"Liao D, Pu T, Tian P. Targeting prostate tumour and its stroma by nanoparticles. J Drug Target. 2025;1\u201318.","DOI":"10.1080\/1061186X.2025.2522868"},{"key":"7196_CR96","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:06:48Z","timestamp":1760458008000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7196"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07196-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures conformed to the Helsinki Declaration for the research on humans. Signed informed consent was obtained from all patients and the experimental research has been performed with the ethical approval provided by the \u201cComitato Etico Regione Calabria, Cosenza, Italy\u201d (approval code: 500\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RL is Associate Editor. MM is Section Editor.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1090"}}